Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M4 Muscarinic Receptor as a Novel Therapeutic Target.

Gogliotti RG, Fisher NM, Stansley BJ, Jones CK, Lindsley CW, Conn PJ, Niswender CM.

J Pharmacol Exp Ther. 2018 May;365(2):291-300. doi: 10.1124/jpet.117.246991. Epub 2018 Mar 9.

PMID:
29523700
2.

The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia.

Stansley BJ, Conn PJ.

Curr Opin Pharmacol. 2018 Feb;38:31-36. doi: 10.1016/j.coph.2018.02.003. Epub 2018 Feb 24. Review.

PMID:
29486374
3.

VU6010608, a Novel mGlu7 NAM from a Series of N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamides.

Reed CW, McGowan KM, Spearing PK, Stansley BJ, Roenfanz HF, Engers DW, Rodriguez AL, Engelberg EM, Luscombe VB, Loch MT, Remke DH, Rook JM, Blobaum AL, Conn PJ, Niswender CM, Lindsley CW.

ACS Med Chem Lett. 2017 Nov 8;8(12):1326-1330. doi: 10.1021/acsmedchemlett.7b00429. eCollection 2017 Dec 14.

PMID:
29259756
4.

Genetic Reduction or Negative Modulation of mGlu7 Does Not Impact Anxiety and Fear Learning Phenotypes in a Mouse Model of MECP2 Duplication Syndrome.

Fisher NM, Gogliotti RG, Vermudez SAD, Stansley BJ, Conn PJ, Niswender CM.

ACS Chem Neurosci. 2017 Dec 14. doi: 10.1021/acschemneuro.7b00414. [Epub ahead of print]

PMID:
29227625
5.

Contextual Fear Extinction Induces Hippocampal Metaplasticity Mediated by Metabotropic Glutamate Receptor 5.

Stansley BJ, Fisher NM, Gogliotti RG, Lindsley CW, Conn PJ, Niswender CM.

Cereb Cortex. 2017 Nov 9:1-14. doi: 10.1093/cercor/bhx282. [Epub ahead of print]

PMID:
29136107
6.

Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation.

Walker AG, Sheffler DJ, Lewis AS, Dickerson JW, Foster DJ, Senter RK, Moehle MS, Lv X, Stansley BJ, Xiang Z, Rook JM, Emmitte KA, Lindsley CW, Conn PJ.

Neuropsychopharmacology. 2017 Dec;42(13):2553-2566. doi: 10.1038/npp.2017.136. Epub 2017 Jun 30.

PMID:
28664928
7.

Behavioral impairments and serotonin reductions in rats after chronic L-dopa.

Stansley BJ, Yamamoto BK.

Psychopharmacology (Berl). 2015 Sep;232(17):3203-13. doi: 10.1007/s00213-015-3980-4. Epub 2015 Jun 3.

8.

L-Dopa and Brain Serotonin System Dysfunction.

Stansley BJ, Yamamoto BK.

Toxics. 2015 Mar 5;3(1):75-88. doi: 10.3390/toxics3010075. Review.

9.

Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus.

Stansley BJ, Yamamoto BK.

J Pharmacol Exp Ther. 2014 Nov;351(2):440-7. doi: 10.1124/jpet.114.218966. Epub 2014 Sep 11.

10.

L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells.

Stansley BJ, Yamamoto BK.

Neuropharmacology. 2013 Apr;67:243-51. doi: 10.1016/j.neuropharm.2012.11.010. Epub 2012 Nov 27.

11.

A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease.

Stansley B, Post J, Hensley K.

J Neuroinflammation. 2012 May 31;9:115. doi: 10.1186/1742-2094-9-115. Review.

Supplemental Content

Loading ...
Support Center